First-in-Human Study of BCX9930 in Healthy Volunteers and Patients With PNH

NCT04330534 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: BCX9930
DRUG: Placebo

Sponsor

BioCryst Pharmaceuticals